Biphasic insulin aspart 30 treatment improves glycemic control among patients with type 2 diabetes in Saudi Arabia and the Gulf region

被引:0
|
作者
Ayad, Nasrat M. [1 ]
Fattah, Waleed A. [2 ]
Bakry, Hani [2 ]
机构
[1] Taiba Hosp, Dept Internal Med, Kuwait, Kuwait
[2] Novo Nordisk Gulf, Dept Med, Riyadh, Saudi Arabia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:919 / 920
页数:2
相关论文
共 50 条
  • [41] Efficacy of biphasic insulin aspart 70/30 in insulin-naive patients with type 2 diabetes mellitus not achieving glycemic targets on oral antidiabetic agents
    Garber, Alan J.
    Jain, Rajeev
    Wahl, Timothy
    Moses, Alan
    Cao, Anjun
    Bressler, Peter
    DIABETES, 2006, 55 : A477 - A477
  • [42] Biphasic insulin aspart 30 in the treatment of elderly patients with type 2 diabetes: a subgroup analysis of the PRESENT Korea NovoMix®study
    Jang, H. C.
    Lee, S. R.
    Vaz, J. A.
    DIABETES OBESITY & METABOLISM, 2009, 11 (01): : 20 - 26
  • [43] Effect of biphasic insulin aspart 30 combined with metformin on glycaemic control in obese people with type 2 diabetes
    Ascic-Buturovic, Belma
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2007, 7 (04) : 335 - 338
  • [44] Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes
    Lindholm, A
    Jensen, LB
    Home, PD
    Raskin, P
    Boehm, BO
    Råstam, J
    DIABETES CARE, 2002, 25 (05) : 876 - 882
  • [45] Biphasic insulin aspart 30 treatment for people with type 2 diabetes: a budget impact analysis based in Thailand
    Deerochanawong, Chaicharn
    Kosachunhanun, Natapong
    Chotikanokrat, Pitthaporn
    Permsuwan, Unchalee
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (02) : 369 - 375
  • [46] Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea
    Bergenstal, Richard
    Lewin, Andrew
    Bailey, Timothy
    Chang, Denise
    Gylvin, Titus
    Roberts, Victor
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (01) : 65 - 75
  • [47] Treatment with biphasic insulin aspart 30 improves glycaemic control in patients with Type 2 diabetes inadequately controlled with oral antidiabetic drugs: results from China cohort in the PRESENT study
    Gao, Yan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 79 : S64 - S65
  • [48] Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with type 2 diabetes
    Schmoelzer, I
    de Campo, A
    Pressl, H
    Stelzl, H
    Dittrich, P
    Oettl, K
    Wascher, TC
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2005, 113 (03) : 176 - 181
  • [49] Factors Affecting Glycemic Control among Saudi Children with Type 1 Diabetes Mellitus in Aseer Region, Southwestern Saudi Arabia
    Al-Qahtani, Saleh M.
    Shati, Ayed A.
    Alqahtani, Youssef A.
    AlAsmari, Ali A.
    Almahdi, Mohammed A.
    Al Hassan, Amjad A.
    Alhassany, Ali M.
    Shathan, Rana A.
    Aldosari, Rawa M.
    AlQahtani, Abdullah S.
    Khalil, Shamsun Nahar
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (18)
  • [50] IMPROVE (TM) observational study of biphasic insulin aspart 30/70 in patients with Type 2 diabetes mellitus
    Kawamori, Ryuzo
    Valensi, Paul
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (04) : 507 - 516